Effects of relaxin in a model of rat adjuvant-induced arthritis

Annals of the New York Academy of Sciences

Volumn 1041, Issue , 2005, Pages 481-485

  Santora, Karen ^a,c   Rasa, Cordelia ^a   Visco, Denise ^a   Steinetz, Bernard ^b   Bagnell, Carol ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Arthritis; Estrogen; Inflammation; Relaxin

Indexed keywords

ADJUVANT; ESTRADIOL; RELAXIN;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOOT RADIOGRAPHY; HORMONAL THERAPY; HORMONE ACTION; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PAW EDEMA; PREGNANCY; RAT; SOFT TISSUE INJURY; TARSAL BONE; TREATMENT OUTCOME;

EID: 23644458764     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1282.072     Document Type: Conference Paper

References (15)

1. WOOD, A.J., Ed. 2004. Therapeutic strategies for rheumatoid arthritis. Drug Therapy 350:2591-2602.
2. LAHITA, R. 2001. Autoimmunity and women's health: is the female immune system different? Women's Health in Primary Care 4: 165-169.
3. LATHAM, K.A., A. ZAMORA, H. DROUGHT, et al. 2003. Estradiol treatment redirects the isotype of the autoantibody response and prevents the development of autoimmune arthritis. J. Immunol. 171: 5820-5827.
4. BANI, D. 1997. Relaxin: a pleiotropic hormone. Gen. Pharmacol. 28: 13-22.
5. UNEMORI, E.N., M. LEWIS, J. CONSTANT, et al. 2000. Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites. Wound Repair Regen. 8: 361-370.
6. PICCINNI, M.P., D. BANI, L. BELONI, et al. 1999. Relaxin favors the development of activated human T cells into Th1-like effectors. Eur. J. Immunol. 29: 2241-2247.
7. MASINI, E., S. NISTRI, A. VANNACCI, et al. 2004. Relaxin inhibits the activation of human neutrophils: involvement of the nitric oxide pathway. Endocrinology 145: 1106-1112.
8. DSCHIETZIG, T., C. BARTSCH, V. STANGL, et al. 2004. Identification of the pregnancy hormone relaxin as glucocorticoid receptor agonist. FASEB J. 18: 1536-1538.
9. GUGASYAN, R., D. CLOUSTON, T. MANDEL, et al. 1997. Prevention of splenic granuloma formation in adjuvant arthritis by 2-acetyl-4- tetrahydroxybutylimidazole (THI). Immunol. Lett. 58: 133-138.
10. BANI, D., S. NISTRI, S. QUATTRONE, et al. 2001. Relaxin causes changes of the liver. In vivo studies in rats. Horm. Metab. Res. 33: 175-180.
11. STEINETZ, B., L. BEACH, R. KROC, et al. 1960. Bioassay of relaxin using a reference standard: a simple and reliable method utilizing direct measurement of interpubic formation in mice. Endocrinology 67: 102-1 15.
12. CLARK, R.L., J.T. CUTTINO, S.K. ANDERLE, et al. 1979. Radiological analysis of arthritis in rats after systemic injection of streptococcal cell walls. Arthritis Rheum. 22: 25-35.
13. THEISEN-POPP, P. & R. MÜLLER-PEDDINGHAUS. 1994. Antirheumatic drug profiles evaluated in the adjuvant arthritis of rats by multiparameter analysis. Agents Actions 42: 50-55.
14. FLETCHER, D.S., W.R. WIDMER, S. LUELL, et al. 1998. Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats. J. Pharmacol. Exp. Ther. 284:714-721.
15. HART, D.A. & C. RENO. 1999. Pregnancy alters gene expression in normal synovium: influence of age and parity. J. Rheumatol. 26: 1775-1784.